September 28, 2025

Periostin as a biomarker of severity and mortality in COVID-19 patients

Key Points

Higher periostin levels are associated with increased severity in COVID-19 patients, affecting outcomes.
Key evidence indicates that elevated periostin concentrations correspond to higher mortality rates in these patients.
Observational analysis explored the relationship between periostin, inflammatory responses, and COVID-19 progression.
Findings highlight periostin's potential as a useful biomarker for assessing risk in COVID-19 patients.

Abstract

Background Periostin is a novel biomarker associated with a range of inflammatory conditions, particularly those involving pulmonary inflammation and fibrotic processes. This research aimed to investigate the association between periostin concentrations, severity of COVID-19, and patient mortality.

Periostin as a biomarker of severity and mortality in COVID-19 patients

Key Points

Abstract

Cite This Study

Also Consider

Also Consider